# Ferring Pharmaceuticals

Rebyota (RBX2660) — 全球首个获批的微生物组液体灌肠剂.

Source: https://cn.bioecon.ru/companies/ferring-pharmaceuticals/
Updated: 2026-07-01

- 国家: Switzerland

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 与 Rebyota 获批及与 Rebiotix Inc（2018 年被收购）原股东的和解协议相关的 €1.21亿款项 | https://www.ferring.com/wp-content/uploads/sites/16/2023/03/Ferring-Pharmaceuticals-Annual-Report-2022.pdf |
| 生产基地 | 美国专用生产设施;明尼苏达州罗斯维尔的Rebiotix, Inc.设施;以及新泽西州帕西帕尼的基因治疗药品专用设施 | https://ferringusa.com/?press=ferring-highlights-commitment-to-c-diff-infection-community-on-the-second-anniversary-of-the-launch-of-rebyota-fecal-microbiota-live-jslm, https://ferringusa.com/wp-content/uploads/sites/12/2022/12/9009000002_REBYOTA-PI_11-2022.pdf |
| 监管批准 | 2022年获 FDA 批准；2025年3月5日获加拿大卫生部批准 | https://www.businesswire.com/news/home/20251029308256/en/Ferring-Pharmaceuticals-to-Explore-Strategic-Options-for-Rebyota, https://www.ferring.ca/media/1385/rebyota-pm-control-no-285129-en-mar-5-2025.pdf, https://www.ferring.com/ferring-receives-u-s-fda-approval-for-rebyota-fecal-microbiota-live-jslm-a-novel-first-in-class-microbiota-based-live-biotherapeutic/, https://www.ferring.com/wp-content/uploads/sites/16/2025/04/Ferring-Pharmaceuticals-Annual-Report-2024.pdf, https://www.ferring.com/wp-content/uploads/sites/16/2026/02/Ferring-Pharmaceuticals-Annual-Report-2023.pdf |
| 员工人数 | 全球超过7,000人(截至2024年);全球超过7,500人(截至2025年);美国超过900人(截至2025年) | https://www.businesswire.com/news/home/20251029308256/en/Ferring-Pharmaceuticals-to-Explore-Strategic-Options-for-Rebyota, https://www.ferring.com/ferring-receives-u-s-fda-approval-for-rebyota-fecal-microbiota-live-jslm-a-novel-first-in-class-microbiota-based-live-biotherapeutic/, https://www.ferring.com/wp-content/uploads/sites/16/2025/04/Ferring-Pharmaceuticals-Annual-Report-2024.pdf |
| 营收 | 全球总收入 €23.43亿（2024 年）；超过 €25亿（2025 年） | https://www.businesswire.com/news/home/20251029308256/en/Ferring-Pharmaceuticals-to-Explore-Strategic-Options-for-Rebyota, https://www.ferring.com/wp-content/uploads/sites/16/2025/04/Ferring-Pharmaceuticals-Annual-Report-2024.pdf |

独立来源: businesswire.com, ferringusa.com

## 技术

- [微生物组治疗药物（活体生物治疗产品）](https://cn.bioecon.ru/technology/microbiome-therapeutics-lbps/)